newsfilter
← Latest News
GlobeNewswire·

Albireo Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

BOSTON, July 26, 2022 (GLOBE NEWSWIRE) -- Albireo Pharma, Inc. (NASDAQ:ALBO), a rare liver disease company developing novel bile acid modulators, today announced the grant of inducement restricted stock units to acquire 16, 200 shares of Albireo's comm